ストックスクリーナーアプリを入手
1.32
0.00%
0.00
前日終値:
$1.32
開ける：
$1.33
24時間の取引高:
5.65M
Relative Volume:
0.76
時価総額：
$842.63M
収益：
$29.48M
当期純損益:
$-201.19M
株価収益率:
-4.125
EPS:
-0.32
ネットキャッシュフロー:
$-216.50M
1週間 パフォーマンス:
-3.65%
1か月 パフォーマンス:
+7.32%
6か月 パフォーマンス:
-5.71%
1年 パフォーマンス:
-63.33%
1日の値動き範囲:
$1.305
$1.36
1週間の範囲:
$1.305
$1.39
52週間の値動き範囲:
$1.04
$3.68
Geron Corp Stock (GERN) Company Profile
名前
Geron Corp
セクター
電話
(650) 473-7700
住所
919 EAST HILLSDALE BOULEVARD, FOSTER CITY, CA
GERN を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
GERN
Geron Corp
|
1.32 | 842.63M | 29.48M | -201.19M | -216.50M | -0.32 |
|
VRTX
Vertex Pharmaceuticals Inc
|
452.13 | 115.03B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
776.31 | 81.12B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
400.17 | 52.54B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
839.99 | 51.78B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
177.12 | 37.12B | 447.02M | -1.18B | -906.14M | -6.1812 |
Geron Corp Stock (GERN) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-07-10 | 再開されました | Goldman | Sell |
| 2025-05-08 | ダウングレード | Scotiabank | Sector Outperform → Sector Perform |
| 2025-02-27 | ダウングレード | B. Riley Securities | Buy → Neutral |
| 2025-02-26 | ダウングレード | H.C. Wainwright | Buy → Neutral |
| 2024-11-05 | 開始されました | H.C. Wainwright | Buy |
| 2024-10-16 | 開始されました | Scotiabank | Sector Outperform |
| 2024-09-09 | 開始されました | Leerink Partners | Outperform |
| 2024-04-30 | ダウングレード | Robert W. Baird | Outperform → Neutral |
| 2024-04-29 | 開始されました | TD Cowen | Buy |
| 2024-03-15 | 繰り返されました | Needham | Buy |
| 2023-09-12 | アップグレード | Goldman | Neutral → Buy |
| 2023-03-28 | 開始されました | Goldman | Neutral |
| 2022-10-28 | 開始されました | Wedbush | Outperform |
| 2022-07-28 | 再開されました | B. Riley Securities | Buy |
| 2021-11-02 | 開始されました | Robert W. Baird | Outperform |
| 2021-02-18 | 再開されました | B. Riley Securities | Buy |
| 2020-08-03 | 開始されました | Stifel | Buy |
| 2019-11-19 | 再開されました | B. Riley FBR | Buy |
| 2019-09-03 | 開始されました | H.C. Wainwright | Buy |
| 2019-08-15 | 開始されました | Cantor Fitzgerald | Overweight |
| 2019-04-09 | アップグレード | Needham | Hold → Buy |
| 2019-01-31 | アップグレード | B. Riley FBR | Neutral → Buy |
| 2018-10-02 | ダウングレード | B. Riley FBR | Buy → Neutral |
| 2018-07-05 | 開始されました | B. Riley FBR, Inc. | Buy |
| 2016-09-13 | 繰り返されました | FBR & Co. | Outperform |
| 2016-09-13 | 繰り返されました | FBR Capital | Outperform |
| 2015-12-07 | 繰り返されました | Piper Jaffray | Overweight |
| 2015-04-21 | 開始されました | Oppenheimer | Outperform |
| 2014-06-12 | アップグレード | MLV & Co | Hold → Buy |
| 2014-03-12 | ダウングレード | MLV & Co | Buy → Hold |
| 2013-12-10 | 繰り返されました | MLV & Co | Buy |
| 2013-12-10 | アップグレード | Needham | Hold → Buy |
| 2013-11-08 | 繰り返されました | MLV & Co | Buy |
| 2013-10-16 | 開始されました | MLV & Co | Buy |
| 2012-08-30 | 開始されました | Stifel Nicolaus | Buy |
| 2012-06-28 | 開始されました | Needham | Hold |
すべてを表示
Geron Corp (GERN) 最新ニュース
Geron (NASDAQ:GERN) Trading Up 4.9%Time to Buy? - MarketBeat
Geron Corporation (GERN) restructuring to lower operating expenses as it eyes profitability in 2026 - MSN
How Geron Corporation stock compares to market leadersJuly 2025 Price Swings & Precise Buy Zone Identification - Улправда
Can Geron Corporation (GON) stock expand revenue streamsWeekly Trade Report & Smart Investment Allocation Insights - Улправда
What margin trends mean for Geron Corporation stock2025 Volatility Report & Weekly High Potential Alerts - Улправда
Geron: From Launch Hype To Later-Line Gravity (NASDAQ:GERN) - Seeking Alpha
Geron (NASDAQ:GERN) Shares Down 3.9%What's Next? - MarketBeat
Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Yahoo Finance
Geron Corporation (GERN) Restructuring to Lower Operating Expenses as it Eyes Profitability in 2026 - Yahoo Finance
Geron (NASDAQ:GERN) Stock Price Up 5.6%Here's What Happened - MarketBeat
14 Best Multibagger Penny Stocks to Buy Right Now - Insider Monkey
Geron Corporation (NASDAQ: GERN) plans workforce cuts, expects $18M charges - Stock Titan
Squarepoint Ops LLC Increases Stock Position in Geron Corporation $GERN - MarketBeat
Bay Area biotech company, down $1.7 billion in value, lays off a third of staff - SFGATE
Geron (NASDAQ:GERN) Trading Up 8.2%What's Next? - MarketBeat
Geron Stock (NASDAQ: GERN) News Today: Restructuring, Analyst Ratings, and 2026 Catalysts (Dec. 12, 2025) - ts2.tech
Geron stock falls as H.C. Wainwright reiterates Neutral rating amid restructuring - Investing.com
Praxis tees up another approval filing; Geron turns to layoffs - Yahoo Finance
Geron Corporation (NASDAQ:GERN) Receives Consensus Rating of "Hold" from Analysts - MarketBeat
Geron Corporation (GERN) Presents New Data at the 67th American Society of Hematology 2025 Annual Meeting - Finviz
Foster City drug maker Geron to lay off one-third of staff under new CEOSan Francisco Business Times - The Business Journals
Geron Corporation: Can Restructuring Bring The Stock Back To Life? I'm On Sidelines (GERN) - Seeking Alpha
Geron Corporation (GERN) Announces Significant Workforce Reducti - GuruFocus
Geron (GERN) Initiates Strategic Restructuring for Long-Term Gro - GuruFocus
Geron to cut workforce by one-third in strategic restructuring - Investing.com
Geron Corporation Announces Strategic Restructuring to Enhance RYTELO® U.S. Commercial Strategy and Reduce Operating Expenses - Quiver Quantitative
Geron (Nasdaq: GERN) plans one-third cut as 2026 operating expenses expected below 2025 - Stock Titan
Here’s Why Geron Corp. (NASDAQ:GERN) Crashed Today - MSN
Geron stock rating reiterated as Neutral by H.C. Wainwright - Investing.com
Geron (GERN) Highlights Promising ASH 2025 Data on RYTELO - GuruFocus
Geron reports early cytopenia may signal response in MDS patients - Investing.com
Geron Corporation Presents New Data on Imetelstat at ASH 2025, Highlighting Clinical Benefits in Lower-Risk Myelodysplastic Syndromes and Myelofibrosis - Quiver Quantitative
Geron (Nasdaq: GERN) presents ASH 2025 RYTELO data on LR-MDS cytopenias, survival trends - Stock Titan
How Geron Corporation (GON) stock correlates with oil marketsWeekly Gains Report & Daily Profit Focused Screening - Newser
Blood Cancer Therapeutics Reach Critical Commercial and Clinical Inflection Points - Benzinga
What consensus target says about Geron Corporation (GON) stockJuly 2025 EndofMonth & High Conviction Buy Zone Picks - Newser
Will Geron Corporation (GON) stock keep raising dividends2025 Investor Takeaways & Reliable Volume Spike Alerts - Newser
Why Geron Corporation (GON) stock stays on buy listsStop Loss & Daily Stock Trend Reports - Newser
Geron Corporation $GERN Stake Increased by Geode Capital Management LLC - MarketBeat
Great week for Geron Corporation (NASDAQ:GERN) institutional investors after losing 71% over the previous year - simplywall.st
Geron Corporation (NASDAQ:GERN) is favoured by institutional owners who hold 64% of the company - Yahoo Finance
Geron Corporation $GERN Shares Sold by Segall Bryant & Hamill LLC - MarketBeat
Wall Street Turns Bullish on Geron Corporation (GERN) amid Rytelo Sales Push Plans - Insider Monkey
10 Fastest Growing Penny Stocks to Buy Now - Insider Monkey
Geron Corporation (GERN) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Market reaction to Geron Corporation’s recent newsPortfolio Update Summary & Daily Stock Momentum Reports - newser.com
Will Geron Corporation stock gain from lower inflationWeekly Trend Recap & Weekly High Potential Alerts - newser.com
Will Geron Corporation (GON) stock extend growth storyWeekly Risk Report & Free AI Powered Buy and Sell Recommendations - newser.com
Why analysts maintain buy rating on Geron Corporation (GON) stockJuly 2025 Earnings & Reliable Entry Point Alerts - newser.com
Geron’s Survival Strategy Faces Critical Test - AD HOC NEWS
Will Geron Corporation stock rally after Fed decisions2025 Technical Overview & Fast Momentum Entry Tips - newser.com
Geron Corp (GERN) 財務データ
収益
当期純利益
現金流量
EPS
Geron Corp (GERN) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| LAWLIS V BRYAN | Director |
May 09 '25 |
Buy |
1.18 |
13,300 |
15,667 |
13,300 |
| Samuels Scott Alan | EVP, Chief Legal Officer |
Feb 27 '25 |
Buy |
1.61 |
15,000 |
24,150 |
26,682 |
| SCARLETT JOHN A | Chairman, President and CEO |
Feb 27 '25 |
Buy |
1.76 |
12,500 |
22,062 |
12,500 |
| Ziegler James | EVP, Chief Commercial Officer |
Feb 27 '25 |
Buy |
1.60 |
100,000 |
160,000 |
100,000 |
0.57%
大文字化:
|
ボリューム (24 時間):